FibroBiologics Files Patent for New Fibroblast-Derived Platform for Orthopedic Indications
The company says its platform may fundamentally change how cartilage loss and degenerative joint disease is treated globally.
Orthopedics News
Medipost to Launch Phase 3 of CARTISTEM, its Cord Blood Stem Cell Therapy, for Knee Osteoarthritis
Based on their results in Korea/Japan, they received a Phase 3 fast track in the USA, and hope to show true cartilage regeneration. Potentially historic moment for the industry coming.
AAOS Launches New Orthobiologics Registry to Improve Knee Osteoarthritis Research
The new registry aims to address evidence gaps and track long-term outcomes for orthobiologic treatments.
Japan Approves JTEC’s Cartilage Cell Therapy for Knee Osteoarthritis, Now Covered by Insurance
The company's autologous cartilage repair product will now be reimbursed under national health insurance, WOMAC scores improved better than hyaluronic acid injections.
Study Finds Bone Marrow-Derived Stem Cells No Better Than Placebo for Chronic Low Back Pain
The trial found no significant difference in pain or function outcomes between bone marrow injections and sham procedures over 12 months, but also had important limitations.
Mesoblast Gets Good FDA Feedback on its Stem Cell Therapy for Back Pain, Rexlemestrocel-L, Progressing Towards BLA
FDA feedback suggests rexlemestrocel-L may reduce chronic back pain and opioid use, Phase 3 underway.
China’s ElpasBio Chooses Fosun Kairos to Commercialize AlloJoin, it’s Stem Cell Therapy for Knee Osteoarthritis
AlloJoin is the first KOA stem cell therapy to reach Phase III in China, and it's gearing up for production soon.
Dark Horse Consulting Acquires Bruder Consulting, Launches New Regenerative Medicine Division
The acquisition brings expanded expertise in regenerative medicine, tissue repair, and biomaterials to Dark Horse Consulting’s service portfolio.
MEDIPOST Files IND for Phase 3 of Umbilical Cord Blood Stem Cell Product, Cartistem, in USA for Knee Osteoarthritis
Building on its momentum in the East, MEDIPOST received a Phase 2 waver, and is heading right for Phase 3 in the US this year. This is one to watch.
Xtant Medical Launches New Synthetic Bone Graft, nanOss Strata, for Enhanced Healing
The new graft material is designed for improved integration with patients' tissues, and it's available through distributors now.
New Korean Stem Cell Hub Coming to Baltimore, Focused on OA and Alzheimer’s Research
Nature Cell’s new facility will focus on stem cell therapeutics, research, and manufacturing, supported by the Maryland Stem Cell Research Fund.
PRP Increases Stem Cell Migration by Activating Key Proteins, Study Finds
Researchers are examining how platelet-rich plasma may help adipose-derived stem cells move more effectively to support muscle repair.
New Review: A Lot of Symptom Relief from Stem Cell Knee Injections May Be Due to Placebo-Type Effects
Is the cart before the horse on orthopedic stem cell therapy?
Keensight Capital Takes Majority Ownership in Orthobiologics Firm Isto Biologics
Keensight Capital’s investment aims to accelerate Isto Biologics’ growth and international expansion in the orthobiologics sector.
Mytos Nabs Cell Manufacturing Deals with StemSight, Rinri Therapeutics, and Novadip
Mytos has developed an automated cell manufacturing platform to serve the cell therapy industry as it matures
Palm Beach Town Council Rejects New Regenerative Medicine Center
Citing concerns over ground-floor medical use, council members debated balancing healthcare access with ongoing retail revitalization in the area.
RION Partners with Lonza for Large-Scale Production of Stem Cell-Derived Exosome Therapies
The partnership will support clinical and future commercial supply of RION’s exosome therapies for tissue repair and regenerative medicine.
Klotho Neurosciences to Acquire Turn Biotechnologies Assets, Secures $300 Million Deal
Klotho Neurosciences expands into cellular reprogramming with a planned Turn Biotechnologies acquisition and significant pharma partnership.
QC Kinetix Revamps Brand and Operations, Improves Average Clinic Profitability by 22.51%
Following a year-long overhaul, QC Kinetix reports improved clinic performance and profitability as it restarts franchise expansion plans.
New Study: Exosome Therapy from Umbilical Cord Stem Cells Shows Early Promise for Osteoarthritis
Researchers are testing whether exosomes from umbilical cord stem cells can safely reduce inflammation and support cartilage repair in osteoarthritis.
Kyoto University Team Creates Jawbone Tissue from Human Stem Cells (iPSCs)
Researchers generated 3D jawbone tissue from induced pluripotent stem cells
NurExone’s Exosomes Outperform Commercial Standard in Regenerative Study
Independent analysis finds NurExone’s exosomes deliver enhanced regenerative signals, showing promise for nerve repair and tissue healing applications.
BioTissue Nabs Vizient Contract to offer Amniotic Allograft Products in the USA
The new agreement enables Vizient members broader access to BioTissue’s amniotic membrane products for diverse clinical applications.
Jagiellonian University Develops New Stem Cell Treatment for Osteoarthritis, Completes Phase 2 Trials
Jagiellonian University researchers advanced an adipose mesenchymal stem cell-based osteoarthritis therapy, showing promising pain reduction and improved joint function in trials.
Exosomes Show Promise in Supporting Bone Fracture Healing and Regeneration
Researchers explored how exosomes could boost bone healing and pave the way for new regenerative therapies.